HRT does not improve urinary albumin excretion in postmenopausal diabetic women.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2003-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8227(02)00279-6PMID 12639763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk

  2002cited by this paper
• Effect of hormone replacement therapy on inflammation‐sensitive proteins in post‐menopausal women with Type 2 diabetes

  2002cited by this paper
• Endothelium-dependent and independent vasodilation studied at normoglycaemia in Type I diabetes mellitus with and without microalbuminuria

  2001cited by this paper
• Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function.

  2001cited by this paper
• Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease

  2001cited by this paper
• The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: a randomized controlled trial.

  2001cited by this paper
• The effects of sequential combined oral 17&bgr;-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study

  2001cited by this paper
• Vascular effects of estrogen in type II diabetic postmenopausal women.

  2001cited by this paper
• Determinants of albuminuria in people with Type 2 diabetes mellitus.

  2001cited by this paper
• Urinary albumin excretion is independently associated with C‐reactive protein levels in overweight and obese nondiabetic premenopausal women

  2001cited by this paper
• Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women.

  2001cited by this paper
• Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women.

  2001cited by this paper
• Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data.

  2001cited by this paper
• The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

  2001cited by this paper
• Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.

  2001cited by this paper
• Differential Effects of Oral and Transdermal Estrogen Replacement Therapy on Endothelial Function in Postmenopausal Women

  2000cited by this paper
• Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

  2000cited by this paper
• The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.

  2000cited by this paper
• Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women.

  1999cited by this paper
• Vascular effects of estrogen and vitamin E therapies in postmenopausal women.

  1999cited by this paper
• Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration.

  1999cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• Estrogen replacement reverses endothelial dysfunction in postmenopausal women.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome

  1997cited by this paper
• Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes

  1996cited by this paper
• Diabetes and Cardiovascular Disease: The “Common Soil” Hypothesis

  1995cited by this paper
• Microalbuminuria and endothelial dysfunction in essential hypertension.

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM

  1992cited by this paper
• Eight to nine year mortality in known non-insulin dependent diabetics and controls.

  1992cited by this paper
• Albuminuria reflects widespread vascular damage

  1989cited by this paper
• Carbohydrate metabolism during hormonal substitution therapy.

  1989cited by this paper
• Single-Void Urine Samples Can Be Used To Estimate Quantitative Microalbuminuria

  1987cited by this paper
• Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

  1987cited by this paper
• A prospective study of postmenopausal estrogen therapy and coronary heart disease.

  1985cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper
• The effect of estrogens on carbohydrate metabolism: glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ethinyl estradiol for six months.

  1972cited by this paper
• Effects of estrogen on glucose tolerance.

  1966cited by this paper

• Effect of Postmenopausal Hormone Therapy on Glucose Regulation in Women With Type 1 or Type 2 Diabetes: A Systematic Review and Meta-analysis.

  2023cites this paper
• Gender Issues in Chronic Kidney Disease

  2020cites this paper
• Effect of age at menarche on microvascular complications among women with Type 1 diabetes

  2019cites this paper
• Older menarche age and short reproductive period linked to chronic kidney disease risk

  2019cites this paper
• Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis

  2018cites this paper
• Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study

  2018cites this paper
• Menopause and Chronic Kidney Disease.

  2017cites this paper
• Sex Hormone Status in Women With Chronic Kidney Disease: Survey of Nephrologists’ and Renal Allied Health Care Providers’ Perceptions

  2017cites this paper
• Sex hormones in women with kidney disease.

  2016cites this paper
• Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes.

  2015cites this paper
• Hormone replacement therapy, renal function and heart ultrasonographic parameters in postmenopausal women: an observational study

  2015cites this paper
• Hormonalna terapia zastêpcza a cukrzyca Hormonal replacement therapy and the diabetes

  2013cites this paper
• 27 Postmenopausal Hormone Therapyand Blood Pressure

  2012cites this paper
• The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease

  2012cites this paper
• Postmenopausal Hormone Therapy and Blood Pressure

  2012cites this paper
• Climacteric Commentaries

  2011cites this paper
• Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice.

  2011cites this paper
• Estrogens and progression of diabetic kidney damage.

  2011cites this paper
• A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study

  2011cites this paper
• Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis.

  2011cites this paper
• The effects of peptides with estrogen‐like activity on cell proliferation and energy metabolism in human derived vascular smooth muscle cells

  2010cites this paper
• Post-menopausal hormone use and albuminuria.

  2009cites this paper
• Sexual dimorphism in the aging kidney: differences in the nitric oxide system

  2009cites this paper
• Sex, diabetes and the kidney.

  2009cites this paper
• Hormone replacement therapy and diabetes

  2008cites this paper
• Effects of estrogen therapy on microalbuminuria in healthy post-menopausal women

  2008cites this paper
• Effect of raloxifene—a selective oestrogen receptor modulator—on kidney function in post‐menopausal women with Type 2 diabetes: results from a randomized, placebo‐controlled pilot trial

  2007cites this paper
• Adjuvant strategies for prevention of glomerulosclerosis.

  2006cites this paper
• Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II.

  2006cites this paper
• The relationship between albuminuria and hormone therapy in postmenopausal women.

  2005cites this paper
• Hormonalna terapia zastępcza a cukrzyca Hormone replacement therapy and diabetes mellitus

  2004cites this paper
• Current literature in diabetes

  2003cites this paper
• Current literature in diabetes.

  2003cites this paper